Ind-Swift Laboratories informs about disclosure

03 Apr 2024 Evaluate
Ind-Swift Laboratories has attached disclosure received by the Company from Essix Biosciences, as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in respect of acquisition of 94,99,720 (Ninety-Four Lakhs Ninety-Nine Thousand Seven Hundred and Twenty) equity shares of Ind-Swift Laboratories by way of inter-se transfer among the promoters.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

106.26 0.31 (0.29%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×